flutiform is the first pressurised metered-dose inhaler to combine the ICS, fluticasone propionate, with the fast-acting inhaled LABA, formoterol. 2 flutiform is licensed for asthma maintenance ...
LONDON, UK, 18 October 2011 - SkyePharma PLC (LSE: SKP) today announces that the review of the European Marketing Authorisation Application ("MAA") for Flutiform TM will take longer than originally ...
DUBLIN--(BUSINESS WIRE)--The "Drug Overview: Flutiform" report has been added to ResearchAndMarkets.com's offering. Flutiform ([fluticasone propionate + formoterol fumarate]; ...
Swedish CDMO Recipharm has struck a $60 million deal to buy Sanofi's contract inhaled medicine business and plant in the U.K. (Sanofi) () Recipharm has struck a deal with Sanofi to buy the French ...
The flutiform k-haler takes its name from a unique kinked valve which removes the need for co-ordination, with only gentle inhalation required to trigger the aerosol. Details of the four flutiform ...
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma. Napp Pharmaceuticals says the UK is ...
LONDON, UK, 1 September 2009 - SkyePharma PLC (LSE: SKP) today provides an update following a meeting held with the US Food and Drug Administration (FDA) to discuss the previously announced potential ...
LONDON, UK, 1 December, 2014 - Skyepharma PLC (LSE SKP), the expert oral and inhalation drug development company, today announces that the 120-puff treatment version in strengths of 50/5µg and 125/5µg ...
LONDON, UK, 20 April, 2012 - SkyePharma PLC (LSE SKP) today announces that the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA") has issued a positive ...
Recipharm, a Swedish drug services firm, will pay $59 million to acquire Sanofi’s inhalation drug business in Holmes Chapel, England. It will get a 125,000-m 2 facility that specializes in metered ...
- flutiform k-haler is now available in Europe as an asthma treatment for adults and adolescents (aged 12 years and older)[1] - Research indicates that many patients make errors with their inhalers ...
LONDON, UK, 20 September, 2013 - Skyepharma PLC (LSE SKP), the expert oral and inhalation drug delivery company, announces that the Japanese Ministry of Health, Labour and Welfare ("MHLW"), has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results